Synthesis of Therapeutic Agents How is human insulin synthesized using recombinant DNA technology? By using chemically synthesized DNA sequences for the complete insulin protein By isolating DNA from the islets of Langerhans of pancreas By using cDNA for insulin By using chemically synthesized DNA sequences for the two chains separately By using chemically synthesized DNA sequences for the complete insulin protein By isolating DNA from the islets of Langerhans of pancreas By using cDNA for insulin By using chemically synthesized DNA sequences for the two chains separately ANSWER DOWNLOAD EXAMIANS APP
Synthesis of Therapeutic Agents The promoter used for cloning HBV surface antigen is polyhedrin β-galactosidase alcohol dehydrogenase 1 galactokinase polyhedrin β-galactosidase alcohol dehydrogenase 1 galactokinase ANSWER DOWNLOAD EXAMIANS APP
Synthesis of Therapeutic Agents Chemically synthesized DNA sequences for the two chains are separately inserted into the plasmid pBR 322 by the side of acid phosphatase glucokinase β-Galactosidase galactokinase acid phosphatase glucokinase β-Galactosidase galactokinase ANSWER DOWNLOAD EXAMIANS APP
Synthesis of Therapeutic Agents Human insulin formed by recombinant DNA technology is known as huinsulin H insulin humulin R insulin huinsulin H insulin humulin R insulin ANSWER DOWNLOAD EXAMIANS APP
Synthesis of Therapeutic Agents The two chains of insulin can be separated by detaching it from β-galactosidase using protease cyanogen bromide hydrogen chloride peptidase protease cyanogen bromide hydrogen chloride peptidase ANSWER DOWNLOAD EXAMIANS APP
Synthesis of Therapeutic Agents In India first genetically engineered vaccine against HBV was developed by Glaxo Pvt Ltd Ranbaxy Pvt Ltd Shantha Biotechnics Pvt Ltd Dabur Pvt Ltd Glaxo Pvt Ltd Ranbaxy Pvt Ltd Shantha Biotechnics Pvt Ltd Dabur Pvt Ltd ANSWER DOWNLOAD EXAMIANS APP
EXAMIANS